[go: up one dir, main page]

WO2007033020A3 - Formulation ophtalmique conçue pour le traitement de la secheresse oculaire - Google Patents

Formulation ophtalmique conçue pour le traitement de la secheresse oculaire Download PDF

Info

Publication number
WO2007033020A3
WO2007033020A3 PCT/US2006/035069 US2006035069W WO2007033020A3 WO 2007033020 A3 WO2007033020 A3 WO 2007033020A3 US 2006035069 W US2006035069 W US 2006035069W WO 2007033020 A3 WO2007033020 A3 WO 2007033020A3
Authority
WO
WIPO (PCT)
Prior art keywords
dry eye
treatment
synthetic
ophthalmic formulation
preservative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/035069
Other languages
English (en)
Other versions
WO2007033020A2 (fr
Inventor
Robert J Meyering
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Publication of WO2007033020A2 publication Critical patent/WO2007033020A2/fr
Publication of WO2007033020A3 publication Critical patent/WO2007033020A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des formulations pour usage topique comprenant des ingrédients actifs 'sécheresse oculaire' homologués de la monographie de la FDA des USA en combinaison d'électrolytes, de glycoprotéines synthétiques, de protéines synthétiques, d'enzymes synthétiques et/ou de peptides synthétiques dans des formulations/systèmes de conservation et sans agents de conservation pour le traitement de la sécheresse oculaire et de l'inflammation associée.
PCT/US2006/035069 2005-09-13 2006-09-08 Formulation ophtalmique conçue pour le traitement de la secheresse oculaire Ceased WO2007033020A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71672405P 2005-09-13 2005-09-13
US60/716,724 2005-09-13

Publications (2)

Publication Number Publication Date
WO2007033020A2 WO2007033020A2 (fr) 2007-03-22
WO2007033020A3 true WO2007033020A3 (fr) 2007-07-19

Family

ID=37865463

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/035069 Ceased WO2007033020A2 (fr) 2005-09-13 2006-09-08 Formulation ophtalmique conçue pour le traitement de la secheresse oculaire

Country Status (1)

Country Link
WO (1) WO2007033020A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170119885A1 (en) * 2014-04-28 2017-05-04 Hampton Technologies Ophthalmic compositions and methods for treating eyes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652209A (en) * 1994-04-29 1997-07-29 University Of Miami Use of secretory products of human lacrimal gland acinar epithelia for tear replacement therapy
US6043213A (en) * 1996-04-19 2000-03-28 R-Tech Ueno, Ltd. Drug composition comprising albumin as active ingredient
US20040126419A1 (en) * 2001-01-30 2004-07-01 Isis Innovation Limited Artificial tear formulation
WO2005084635A2 (fr) * 2004-03-02 2005-09-15 Institute Of Ophthalmology Preparations pharmaceutiques destinees aux troubles de la surface oculaire et a d'autres troubles et traitement correspondant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652209A (en) * 1994-04-29 1997-07-29 University Of Miami Use of secretory products of human lacrimal gland acinar epithelia for tear replacement therapy
US6043213A (en) * 1996-04-19 2000-03-28 R-Tech Ueno, Ltd. Drug composition comprising albumin as active ingredient
US20040126419A1 (en) * 2001-01-30 2004-07-01 Isis Innovation Limited Artificial tear formulation
WO2005084635A2 (fr) * 2004-03-02 2005-09-15 Institute Of Ophthalmology Preparations pharmaceutiques destinees aux troubles de la surface oculaire et a d'autres troubles et traitement correspondant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OHASHI ET AL: "Laboratory findings in tear fluid analysis", CLINICA CHIMICA ACTA, AMSTERDAM, NL, vol. 369, no. 1, 15 July 2006 (2006-07-15), pages 17 - 28, XP005465744, ISSN: 0009-8981 *
ZHOU L ET AL: "Characterisation of human tear proteins using high-resolution mass spectrometry", ANNALS OF THE ACADEMY OF MEDICINE, SINGAPORE, ACADEMY OF MEDICINE, SG, vol. 35, no. 6, June 2006 (2006-06-01), pages 400 - 407, XP009074070, ISSN: 0304-4602 *

Also Published As

Publication number Publication date
WO2007033020A2 (fr) 2007-03-22

Similar Documents

Publication Publication Date Title
WO2006082588A3 (fr) Procede et dispositif d'administration ophtalmique d'ingredients pharmaceutiquement actifs
WO2003064449A3 (fr) Peptides bioactifs de keratine
EP2422794A3 (fr) Compositions comprenant des cellules souches embryonnaires humaines et leurs dérivés, procédés d'utilisation et procédés de préparation
WO2006055454A3 (fr) Compositions ophtalmiques et procedes de traitement oculaire
WO2002009637A3 (fr) Compositions pharmaceutiques permettant le traitement d'etats pathologiques douloureux, inflammatoires et ulcereux de surfaces epitheliales humides, tels que la mucosite, la stomatite et le syndrome de behcet
WO2003030824A3 (fr) Methodes et compositions pour le traitement de lesions cutanees
WO2008111562A1 (fr) Agent de blanchiment
WO2009044279A3 (fr) Peptide présentant une activité antimicrobienne et/ou bio-tensioactive
WO2002049615A3 (fr) Composition de larmes artificielles contenant une combinaison de trois emollients
WO2001034641A3 (fr) Activite antimicrobienne du premier groupe cationique de la lactoferrine humaine
WO2004009038A3 (fr) Preparations cosmetiques a proprietes antibacteriennes
AU2003296692A1 (en) Lipidic protein-transfer systems and cosmetic/dermatological use thereof
WO2007134118A3 (fr) Composition à base de protéines et méthodes d'utilisation
WO2008145849A3 (fr) Composition pharmaceutique et/ou cosmetique contenant des peptides derives de l'aconitase
CA2494473A1 (fr) Compositions de proteines stabilisees pour administration topique et methodes pour les produire
WO2007135268A3 (fr) Utilisation de peptides en tant que principes actifs amincissants
CA2420640A1 (fr) Preparations combinees de derives d'acide 3-n-formyl- hydroxyamino-propylphosphonique ou de derives d'acide 3-n- acethyl-hydroxyamino-propylphosphonique avec ingredients speciaux pharmaceutiquement actifs
AU1169999A (en) Aqueous ophthalmic formulations comprising chitosan
WO2007033020A3 (fr) Formulation ophtalmique conçue pour le traitement de la secheresse oculaire
WO2006018454A3 (fr) Preparation cosmetique contenant de l'acide hyaluronique
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
WO2005007071A3 (fr) Formulation pour la peau
WO2007050369A3 (fr) Compositions analgesiques topiques de n,2,3-trimethyl-2-isopropylbutamide et procedes pour les utiliser
WO2007082864A3 (fr) Utilisation du chavicol comme antiseptique
WO2003050190A3 (fr) Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06814350

Country of ref document: EP

Kind code of ref document: A2